Bleomycin Sulfate
2 NDCs across 2 manufacturers|2 Generic,0 Brand
Bleomycin Sulfate is used to treat squamous cell carcinoma, choriocarcinoma, hodgkin disease, non-hodgkin lymphoma, melanoma and sarcoma, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jun 1, 1996. In 2024, Medicare Part D spent $1K on Bleomycin Sulfate across 16 claims.
Bleomycin Sulfate is available as 2 NDCs from 2 manufacturers (2 generic, 0 brand), with NADAC prices from $26.45 to $26.45 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
2G / 0B
Manufacturers
2
competing in market
Price Spread
$26.45 – $26.45
per EA
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Fresenius Kabi USA, LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Cytoprotective Agent class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing BLEOMYCIN SULFATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
BLEOMYCIN SULFATE 15 UNIT VIAL | $26.4480 per EA | — |
BLEOMYCIN SULFATE 15 UNIT VIAL | $26.4480 per EA | — |
Frequently Asked Questions
What is Bleomycin Sulfate used to treat?
Bleomycin Sulfate is used to treat squamous cell carcinoma, choriocarcinoma, hodgkin disease, non-hodgkin lymphoma, melanoma and sarcoma, per the National Library of Medicine's MED-RT classification.
When did Bleomycin Sulfate become available as a generic?
FDA approved the first generic Bleomycin Sulfate (ANDA) on Jun 1, 1996.
How much does Medicare spend on Bleomycin Sulfate?
In 2024, Medicare Part D spent $1K on Bleomycin Sulfate across 16 claims.
How many Bleomycin Sulfate products are on the market?
The Bleomycin Sulfate drug market contains 2 NDCs from 2 manufacturers — 2 generic and 0 brand products.
What is the price range for Bleomycin Sulfate?
NADAC reference prices for Bleomycin Sulfate range from $26.4480 to $26.4480 per EA.
Which manufacturers make Bleomycin Sulfate?
2 manufacturers list Bleomycin Sulfate in NADAC. Ranked by number of NDCs, the largest are Fresenius Kabi USA, LLC (1), Meitheal Pharmaceuticals Inc. (1).